Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
| Revenue (Most Recent Fiscal Year) | $12.16B |
| Net Income (Most Recent Fiscal Year) | $418.00M |
| PE Ratio (Current Year Earnings Estimate) | 14.01 |
| PE Ratio (Trailing 12 Months) | 14.94 |
| PEG Ratio (Long Term Growth Estimate) | 1.56 |
| Price to Sales Ratio (Trailing 12 Months) | 1.36 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.24 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 10.23 |
| Pre-Tax Margin (Trailing 12 Months) | 4.68% |
| Net Margin (Trailing 12 Months) | 3.24% |
| Return on Equity (Trailing 12 Months) | 13.99% |
| Return on Assets (Trailing 12 Months) | 6.82% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.17 |
| Quick Ratio (Most Recent Fiscal Quarter) | 1.02 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.52 |
| Inventory Turnover (Trailing 12 Months) | 18.47 |
| Book Value per Share (Most Recent Fiscal Quarter) | $92.76 |
| Earnings per Share (Most Recent Fiscal Quarter) | $3.30 |
| Earnings per Share (Most Recent Fiscal Year) | $13.56 |
| Diluted Earnings per Share (Trailing 12 Months) | $4.67 |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Common Shares Outstanding | 84.13M |
| Free Float | 83.41M |
| Market Capitalization | $17.49B |
| Average Volume (Last 20 Days) | 0.67M |
| Beta (Past 60 Months) | 1.01 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.85% |
| Percentage Held By Institutions (Latest 13F Reports) | 95.94% |
| Annual Dividend (Based on Last Quarter) | $2.88 |
| Dividend Yield (Based on Last Quarter) | 1.38% |